Visible and Sub-visible Particle Formation for a Model Bioconjugate

被引:0
|
作者
Lavinia M. Lewis
Michelle E. Pizzo
Sandipan Sinha
Syed S. Ahmed
Liji Joseph
机构
[1] Biotherapeutics Pharmaceutical Sciences,Division of Pharmaceutical Sciences
[2] Pfizer,undefined
[3] School of Pharmacy,undefined
[4] Gilead,undefined
来源
AAPS PharmSciTech | 2017年 / 18卷
关键词
bioconjugate; interfacial area; kinetics; sub-visible particles; visible particles;
D O I
暂无
中图分类号
学科分类号
摘要
The time-course and extent of visible particle (VP) and sub-visible particle (SVP) formation was monitored as a function of interfacial area (IA) for a model bioconjugate. To facilitate particle formation, the bioconjugate was agitated in a glass vial and exposed to IAs up to 478 mm2. Since vials had equal fill and headspace volumes, the area of the air-water interface was varied by placing vials on angled blocks at 0°, 30°, 60°, or 90° from the horizontal. A significant increase in visible and sub-visible particle formation was observed with increasing air-water IA. Exposure to IAs below ∼305 mm2 resulted in the formation of very few particles, while IAs > ∼305 mm2 resulted in substantial particle formation. Visible and sub-visible particle morphology varied with interfacial area and time. The sub-visible particles initially increased with time but did not reach steady state; instead the initial increase was followed by complete depletion. These phenomena indicate that visible particle formation likely increased at the expense of the sub-visible particle population and demonstrate a potential link between the two particle populations for this model bioconjugate. Initiation of particle formation did not result in corresponding decreases in protein concentration or increases in soluble aggregates. However, extended agitation time resulted in a significant decrease in protein concentration.
引用
收藏
页码:926 / 931
页数:5
相关论文
共 50 条
  • [21] Evaluation of sub-visible particles in recombinant humanized monoclonal antibody formulations
    Yang, Jessica Y.
    Yin, Jian
    Andya, James
    Kabakoff, Bruce
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [22] PHYSIOLOGICAL-EFFECTS OF SUB-VISIBLE MICROSPHERES ADMINISTERED INTRAVENOUSLY TO BEAGLE DOGS
    SCHROEDER, HG
    BIVINS, BA
    SHERMAN, GP
    DELUCA, PP
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (04) : 508 - 513
  • [23] Sensitivity and Uncertainty Analysis of Micro-Flow Imaging for Sub-Visible Particle Measurements Using Artificial Neural Network
    Sadegh Poozesh
    Flavio Cannavò
    Prakash Manikwar
    Pharmaceutical Research, 2023, 40 : 721 - 733
  • [24] DISTRIBUTION OF RADIOLABELED SUB-VISIBLE MICROSPHERES AFTER INTRAVENOUS ADMINISTRATION TO BEAGLE DOGS
    SCHROEDER, HG
    SIMMONS, GH
    DELUCA, PP
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (04) : 504 - 507
  • [25] Assessment of protein aggregates and sub-visible particles in different recombinant FVIII preparations
    Malisauskas, M.
    Lubich, C.
    Prenninger, T.
    Matthiessen, P.
    Turecek, P.
    Scheiflinger, F.
    Reipert, B. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 31 - 31
  • [26] Sub-Visible Particle Classification and Label Consistency Analysis for Flow-Imaging Microscopy Via Machine Learning Methods
    Rio, Angela Lopez-del
    Pacios-Michelena, Anabel
    Picart-Armada, Sergio
    Garidel, Patrick
    Nikels, Felix
    Kube, Sebastian
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 113 (04) : 880 - 890
  • [27] Sensitivity and Uncertainty Analysis of Micro-Flow Imaging for Sub-Visible Particle Measurements Using Artificial Neural Network
    Poozesh, Sadegh
    Cannavo, Flavio
    Manikwar, Prakash
    PHARMACEUTICAL RESEARCH, 2023, 40 (03) : 721 - 733
  • [28] A method to measure the sub-visible ink content of low-consistency whitewater streams
    Lavery, HP
    1996 PROCESS & PRODUCT QUALITY CONFERENCE, 1996, : 3 - 6
  • [29] Small Amounts of Sub-Visible Aggregates Enhance the Immunogenic Potential of Monoclonal Antibody Therapeutics
    Maryam Ahmadi
    Christine J. Bryson
    Edward A. Cloake
    Katie Welch
    Vasco Filipe
    Stefan Romeijn
    Andrea Hawe
    Wim Jiskoot
    Matthew P. Baker
    Mark H. Fogg
    Pharmaceutical Research, 2015, 32 : 1383 - 1394
  • [30] Small Amounts of Sub-Visible Aggregates Enhance the Immunogenic Potential of Monoclonal Antibody Therapeutics
    Ahmadi, Maryam
    Bryson, Christine J.
    Cloake, Edward A.
    Welch, Katie
    Filipe, Vasco
    Romeijn, Stefan
    Hawe, Andrea
    Jiskoot, Wim
    Baker, Matthew P.
    Fogg, Mark H.
    PHARMACEUTICAL RESEARCH, 2015, 32 (04) : 1383 - 1394